Steve Trifilio

1.7k total citations
16 papers, 1.2k citations indexed

About

Steve Trifilio is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, Steve Trifilio has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Steve Trifilio's work include Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (6 papers) and Neutropenia and Cancer Infections (3 papers). Steve Trifilio is often cited by papers focused on Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (6 papers) and Neutropenia and Cancer Infections (3 papers). Steve Trifilio collaborates with scholars based in United States, Australia and Philippines. Steve Trifilio's co-authors include Jayesh Mehta, Andrew M. Evens, Martin S. Tallman, Jingbo Pi, Dennis W. Raisch, June M. McKoy, Charles L. Bennett, Seema Singhal, Leo I. Gordon and Jane N. Winter and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Steve Trifilio

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Trifilio United States 11 507 447 309 262 167 16 1.2k
Lambert F. R. Span Netherlands 20 708 1.4× 675 1.5× 152 0.5× 121 0.5× 141 0.8× 45 1.4k
Donna Salzman United States 18 302 0.6× 372 0.8× 368 1.2× 358 1.4× 114 0.7× 57 1.2k
D. J. Winston United States 21 395 0.8× 791 1.8× 322 1.0× 524 2.0× 348 2.1× 33 1.7k
Xaver Schiel Germany 19 267 0.5× 542 1.2× 570 1.8× 134 0.5× 133 0.8× 36 1.2k
Steven Trifilio United States 18 361 0.7× 353 0.8× 398 1.3× 231 0.9× 65 0.4× 55 1.3k
David Bodensteiner United States 18 866 1.7× 771 1.7× 363 1.2× 334 1.3× 220 1.3× 35 1.7k
Helen Leather United States 23 1.1k 2.2× 1.1k 2.4× 641 2.1× 666 2.5× 107 0.6× 49 2.3k
Hamdi Akan Türkiye 26 602 1.2× 775 1.7× 555 1.8× 471 1.8× 168 1.0× 106 1.8k
Luana Fianchi Italy 28 687 1.4× 772 1.7× 565 1.8× 778 3.0× 105 0.6× 91 2.3k
LeAnne Kennedy United States 12 264 0.5× 450 1.0× 189 0.6× 278 1.1× 51 0.3× 33 981

Countries citing papers authored by Steve Trifilio

Since Specialization
Citations

This map shows the geographic impact of Steve Trifilio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Trifilio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Trifilio more than expected).

Fields of papers citing papers by Steve Trifilio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Trifilio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Trifilio. The network helps show where Steve Trifilio may publish in the future.

Co-authorship network of co-authors of Steve Trifilio

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Trifilio. A scholar is included among the top collaborators of Steve Trifilio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Trifilio. Steve Trifilio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
3.
Garg, Vishvas, Dennis W. Raisch, June M. McKoy, et al.. (2011). PCN23 IMPACT OF US FOOD AND DRUG ADMINISTRATION'S BLACK BOX WARNINGS ON ADVERSE EVENTS REPORTING RATES FOR MULTIPLE MYELOMA DRUGS. Value in Health. 14(3). A158–A159. 1 indexed citations
4.
Raisch, Dennis W., Charles L. Bennett, John S. Esterly, et al.. (2010). Evaluation of a Potential Clinical Interaction between Ceftriaxone and Calcium. Antimicrobial Agents and Chemotherapy. 54(4). 1534–1540. 34 indexed citations
5.
Trifilio, Steve, Marc H. Scheetz, Jingbo Pi, & Minesh P. Mehta. (2009). Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring. Bone Marrow Transplantation. 45(8). 1352–1356. 33 indexed citations
6.
Edwards, Beatrice J., Mrinal M. Gounder, June M. McKoy, et al.. (2008). Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. The Lancet Oncology. 9(12). 1166–1172. 107 indexed citations
7.
Mehta, Jayesh, et al.. (2008). Variation in melphalan dosing in myeloma patients undergoing high-dose chemotherapy and autotransplantation. Journal of Clinical Oncology. 26(15_suppl). 7047–7047.
8.
Scheetz, Marc H., June M. McKoy, Jorge P. Parada, et al.. (2007). Systematic Review of Piperacillin-Induced Neutropenia. Drug Safety. 30(4). 295–306. 45 indexed citations
9.
Trifilio, Steve, Seema Singhal, Stephanie Williams, et al.. (2007). Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplantation. 40(5). 451–456. 170 indexed citations
10.
Trifilio, Steve, Gennethel Pennick, Judy Pi, et al.. (2007). Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients. Cancer. 109(8). 1532–1535. 153 indexed citations
11.
McKoy, June M., Cara Angelotta, Charles L. Bennett, et al.. (2006). Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project. Leukemia Research. 31(5). 599–604. 129 indexed citations
12.
Trifilio, Steve, Seema Singhal, Stephanie Williams, et al.. (2006). Breakthrough Fungal Infections after Allogeneic Hematopoietic Stem Cell Transplantation in Patients on Prophylactic Voriconazole.. Blood. 108(11). 2849–2849. 8 indexed citations
13.
Trifilio, Steve, Roberto Ortiz, Gennethel Pennick, et al.. (2005). Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplantation. 35(5). 509–513. 143 indexed citations
14.
Eklund, John, Steve Trifilio, & Mary F. Mulcahy. (2005). Chemotherapy dosing in the setting of liver dysfunction.. PubMed. 19(8). 1057–63; discussion 1063. 73 indexed citations
15.
Bennett, Charles L., Stefano Luminari, Allen R. Nissenson, et al.. (2004). Pure Red-Cell Aplasia and Epoetin Therapy. New England Journal of Medicine. 351(14). 1403–1408. 284 indexed citations
16.
Slimack, Nicholas P., Stephen A. Klinge, Steve Trifilio, et al.. (2004). Gemcitabine-associated interstitial pneumonitis: Comprehensiveness and clinical characteristics of FDA and medical literature cases. Journal of Clinical Oncology. 22(14_suppl). 7229–7229. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026